TY - JOUR
T1 - Microfluidic coaxial 3D bioprinting of cell-laden microfibers and microtubes for salivary gland tissue engineering
AU - Yin, Yu
AU - Vázquez-Rosado, Ephraim J.
AU - Wu, Danielle
AU - Viswananthan, Vignesh
AU - Farach, Andrew
AU - Farach-Carson, Mary C.
AU - Harrington, Daniel A.
N1 - Funding Information:
This work was supported by the National Science Foundation CAREER award 2240008 to D.A.H., National Institutes of Health / National Institute of Dental and Craniofacial Research (NIH/NIDCR) grants R03DE028988 to D.A.H. and R56DE026530 to M.C.F-C; National Cancer Institute grant P01CA257907 to Dr. Quynh-Thu Le at Stanford University for tissue collection support; UTHSC-H startup funding to D.A.H; UTSTARS Award to M.C.F-C supporting the bioprinter and microscopy facilities. E.J.V-R. was supported by NIH RISE-E-BASE grant R25GM127191 . The authors acknowledge Rachel Hildebrand, a research coordinator in Dr. Quynh-Thu Le's group, who helped to consent patients for human parotid tissue collections. The authors thank Caitlynn Barrows for explanting parotid tissue from Houston Methodist Hospital and Dr. Nadia Mohyuddin at Houston Methodist Hospital for providing surgical specimens. Thanks to Dr. Erin Bedford at Aspect Biosystems for her technical support of the bioprinter.
Publisher Copyright:
© 2023
PY - 2023/11
Y1 - 2023/11
N2 - Replacement therapy for the salivary gland (SG) remains an unmet clinical need. Xerostomia (“dry mouth”) due to hyposalivation can result from injury or disease to the SG, such as salivary acinar death caused by radiation therapy (RT) for head and neck squamous cell carcinoma (HNSCC). Currently, only palliative treatments exist for xerostomia, and many patients endure deteriorated oral health and poor quality of life. Tissue engineering could offer a permanent solution for SG replacement by isolating healthy SG tissues prior to RT, expanding its cells in vitro, and recreating a functional salivary neogland for implantation post-RT. 3D bioprinting methods potentiate spatial cell deposition into defined hydrogel-based architectures, mimicking the thin epithelia developed during the complex branching morphogenesis of SG. By leveraging a microfluidics-based bioprinter with coaxial polymer and crosslinker streams, we fabricated thin, biocompatible, and reproducible hydrogel features that recapitulate the thin epithelia characteristics of SG. This flexible platform enabled two modes of printing: we produced solid hydrogel fibers, with diameters <100 μm, that could be rastered to create larger mm-scale structures. By a second method, we generated hollow tubes with wall thicknesses ranging 45–80 μm, total tube diameters spanning 0.6–2.2 mm, and confirmed tube patency. In both cases, SG cells could be printed within the thin hydrogel features, with preserved phenotype and high viability, even at high density (5.0 × 106 cells/mL). Our work demonstrates hydrogel feature control across multiple length scales, and a new paradigm for addressing SG restoration by creating microscale tissue engineered components.
AB - Replacement therapy for the salivary gland (SG) remains an unmet clinical need. Xerostomia (“dry mouth”) due to hyposalivation can result from injury or disease to the SG, such as salivary acinar death caused by radiation therapy (RT) for head and neck squamous cell carcinoma (HNSCC). Currently, only palliative treatments exist for xerostomia, and many patients endure deteriorated oral health and poor quality of life. Tissue engineering could offer a permanent solution for SG replacement by isolating healthy SG tissues prior to RT, expanding its cells in vitro, and recreating a functional salivary neogland for implantation post-RT. 3D bioprinting methods potentiate spatial cell deposition into defined hydrogel-based architectures, mimicking the thin epithelia developed during the complex branching morphogenesis of SG. By leveraging a microfluidics-based bioprinter with coaxial polymer and crosslinker streams, we fabricated thin, biocompatible, and reproducible hydrogel features that recapitulate the thin epithelia characteristics of SG. This flexible platform enabled two modes of printing: we produced solid hydrogel fibers, with diameters <100 μm, that could be rastered to create larger mm-scale structures. By a second method, we generated hollow tubes with wall thicknesses ranging 45–80 μm, total tube diameters spanning 0.6–2.2 mm, and confirmed tube patency. In both cases, SG cells could be printed within the thin hydrogel features, with preserved phenotype and high viability, even at high density (5.0 × 106 cells/mL). Our work demonstrates hydrogel feature control across multiple length scales, and a new paradigm for addressing SG restoration by creating microscale tissue engineered components.
KW - 3D bioprinting
KW - Biomaterials
KW - Hydrogels
KW - Salivary gland
KW - Sodium alginate
KW - Tissue engineering
UR - http://www.scopus.com/inward/record.url?scp=85168810284&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85168810284&partnerID=8YFLogxK
U2 - 10.1016/j.bioadv.2023.213588
DO - 10.1016/j.bioadv.2023.213588
M3 - Article
C2 - 37634337
AN - SCOPUS:85168810284
SN - 2772-9508
VL - 154
JO - Biomaterials Advances
JF - Biomaterials Advances
M1 - 213588
ER -